Di Lorenzo, Giuseppe
 Distribuzione geografica
Continente #
AS - Asia 751
SA - Sud America 345
NA - Nord America 164
EU - Europa 139
AF - Africa 14
OC - Oceania 3
Totale 1.416
Nazione #
SG - Singapore 581
BR - Brasile 320
US - Stati Uniti d'America 98
HK - Hong Kong 96
IT - Italia 72
MX - Messico 43
CA - Canada 16
NL - Olanda 16
DE - Germania 13
GB - Regno Unito 11
ID - Indonesia 11
UA - Ucraina 11
BD - Bangladesh 10
AR - Argentina 9
CN - Cina 9
TR - Turchia 7
IN - India 6
UZ - Uzbekistan 6
IQ - Iraq 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
EC - Ecuador 4
MA - Marocco 4
RU - Federazione Russa 4
AU - Australia 3
CO - Colombia 3
ES - Italia 3
ET - Etiopia 3
FR - Francia 3
JO - Giordania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
CH - Svizzera 2
GR - Grecia 2
JM - Giamaica 2
PK - Pakistan 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AL - Albania 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
UY - Uruguay 1
Totale 1.416
Città #
Singapore 408
Hong Kong 81
Mexico City 40
Rome 28
São Paulo 20
Naples 14
Brasília 10
Rio de Janeiro 10
Beijing 9
Chicago 8
Belo Horizonte 6
Salvador 6
Tashkent 6
Milan 5
Contagem 4
Dhaka 4
Goiânia 4
Nepean 4
Uberlândia 4
Amman 3
Bragança Paulista 3
Campinas 3
Curitiba 3
João Pessoa 3
Juiz de Fora 3
New York 3
Porto Alegre 3
Praia Grande 3
San Lorenzello 3
Sete Lagoas 3
Vancouver 3
Abbotsford 2
Adana 2
Addis Ababa 2
Anaheim 2
Ashburn 2
Atlanta 2
Baghdad 2
Baku 2
Belém 2
Bridgetown 2
Buenos Aires 2
Calvisano 2
Campina Grande do Sul 2
Canaã dos Carajás 2
Cape Town 2
Caxias do Sul 2
Cesena 2
Charlotte 2
Colíder 2
Conceição do Mato Dentro 2
Dallas 2
Divinópolis 2
Domicella 2
Dubai 2
Francisco Morato 2
Goianésia 2
Governador Valadares 2
Guarulhos 2
Guayaquil 2
Hamilton 2
Irecê 2
Istanbul 2
Itu 2
Johannesburg 2
Limeira 2
Macapá 2
Maracaibo 2
Mariana 2
Medina 2
Melbourne 2
Nova Lima 2
Ouro Preto 2
Oxford 2
Palermo 2
Passo Fundo 2
Pelotas 2
Pouso Alegre 2
Rabat 2
Recife 2
Ribeirão Preto 2
Rio Claro 2
Rostov-on-Don 2
Salt Lake City 2
Santa Maria 2
Santo André 2
Schlieren 2
Sobral 2
Sorocaba 2
Tampa 2
Toledo 2
Toronto 2
Tramandaí 2
Valparaíso de Goiás 2
Venice 2
Volta Redonda 2
Abaeté 1
Agadir 1
Alagoinhas 1
Alfortville 1
Totale 841
Nome #
Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients 33
Clinical characteristics of metastatic prostate cancer patients infected with COVID-19 in South Italy 20
Validation of Psychometric Tools for Assessing Fatigue, Mood, and Sleep Quality: Application in the PREVES-STOP Study. 17
Impact of Dietary Supplements on Clinical Outcomes and 2 Quality of Life in Patients with Breast Cancer: A Systematic Review 12
Development and Validation of the PREVESMED Questionnaire: A Comprehensive Tool for Assessing Adherence to a Mediterranean Lifestyle 11
Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy 11
A case of renal melanoma metastasis: Description of clinico-pathological features 11
Everolimus as second-line therapy for metastatic renal cell carcinoma: a 'real-life' study 11
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers 10
READY: Real-world data from an Italian compassionate use program of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) 10
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial 9
Thermal and fluid dynamic behaviors of confined laminar impinging slot jets with nanofluids 9
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial 9
Focus on localized laryngeal amyloidosis: Management of five cases 9
Combination therapy for metastatic renal cell carcinoma 9
Predicting early and delayed bleedings in children who undergo adeno-tonsillectomy surgery. Is it really possible? 9
Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors 9
KIDNEY CANCER Overall survival is an unsuitable primary end point 9
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update 8
An evolving role for immunotherapy in metastatic RCC 8
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen 8
Prostate Cancer Detection in the "Grey Area" of Prostate-Specific Antigen Below 10 ng/ml: Head-to-Head Comparison of the Updated PCPT Calculator and Chun's Nomogram, Two Risk Estimators Incorporating Prostate Cancer Antigen 3 8
Matrix metalloproteinase-2 and-9 in the urine of prostate cancer patients 8
Instant messaging in cancer care 8
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis 8
Expression of HECA-452 in parapsoriasis and mycosis fungoides 8
Optimal management of a patient with recurrent nasopharyngeal carcinoma 8
A Prognostic Model for Patients With Metastatic Renal Cell Cancer: What's New? 8
Chirurgia conservativa e qualità di vita in pazienti con carcinoma renale localizzato. 8
INCREASED EXPRESSION OF THE AUTOCRINE MOTILITY FACTOR IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH CLEAR CELL – RENAL CELL CARCINOMA 8
ADVERSE EVENTS 1 OF IMMUNE CHECKPOINT INHIBITORS THERAPYFOR UROLOGIC CANCER PATIENTS IN CLINICAL TRIALS: A COLLABORATIVE SYSTEMATIC REVIEW AND META ANALYSIS 8
Paclitaxel in Pretreated Metastatic Penile Cancer: Final Results of a Phase 2 Study 8
A comprehensive outlook on intracerebral therapy of malignant gliomas. 8
Medical expulsive treatment of distal-ureteral stones using tamsulosin: A single-center experience 8
Kaempferol, myricetin and fisetin in prostate and bladder cancer: A systematic review of the literature 7
Predictors of Residual T1 High Grade on Re- Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer 7
Immunotherapy for the treatment of prostate cancer 7
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 7
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma 7
TUMORI UROLOGICI: TUMORI DEL TESTICOLO, PROSTATA, RENE E VESCICA 7
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals, and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy: Insights from the BLOSSOM Study and Beyond 7
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 7
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report study 7
Incidence of fatigue and low dose of corticosteroids in patients receiving systemic treatment: a metanalysis of randomized trials 7
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: A phase II study 7
Outcomes associated with first-line PD-1 and PD-L1 inhibitors vs. sunitinib in patients with renal cell cancer with sarcomatoid features: a systematic review and meta-analysis 7
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis 7
Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients 7
Computed-Tomography-Structured Reporting in Middle Ear Opacification: Surgical Results and Clinical Considerations From a Large Retrospective Analysis 7
Myrtucommulone Production by a Strain of Neofusicoccum australe Endophytic in Myrtle. 7
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis 7
Management of AIDS-related Kaposi's sarcoma 7
The role of immunotherapy in oncology 7
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 7
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results 7
An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples (vol 12, pg 1491, 2011) 7
The Development and Initial Validation of the REST Questionnaire: A Multidimensional Tool for Assessing Fatigue in Individuals with and Without a History of Cancer 7
Words of Wisdom. Re: Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy 7
Kaempferol, myricetin and fisetin in prostate and bladder cancer: a systematic review of literature 7
Nature's hidden gem: quercitrin's promising role in preventing prostate and bladder cancer 7
The Influence of Prednisone on the Efficacy of Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer 7
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 7
Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience 6
Phase II trial of gemcitabine, prednisone, and zoledronic acid in pretreated patients with hormone refractory prostate cancer 6
TUMORI UROLOGICI: PROSTATA, RENE E VESCICA 6
The use of tamsulosin in the medical treatment of ureteral calculi: Where do we stand? 6
Testicular cancer from diagnosis to epigenetic factors 6
Long lasting response to second-line everolimus in kidney cancer. 6
Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients 6
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: a systematic review and meta-analysis 6
Coronavirus disease (COVID-19) in Italy: Analysis of risk factors and proposed remedial measures 6
Optimal Management of Metastatic Castration-Resistant Prostate Cancer:Highlights from a European Expert Consensus Panel 6
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study 6
Nefrectomia citoriduttiva e palliativa 6
Imatinib mesylate in thymic epithelial malignancies 6
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 6
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2-10 ng/ml 6
Soluble interleukin-6 receptor to interleukin-6 (sIL-6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy 6
Concurrent Chemoradiotherapy for Men With Locally Advanced Penile Squamous Cell Carcinoma 6
New perspectives in the therapy of castration resistant prostate cancer 6
Hypercastration in prostate cancer 6
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy 6
Tumor to tumor metastasis: breast cancer metastatic to thymic epithelial tumor 6
Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132–1142 6
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era 6
Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis 6
A Challenging Surgical Approach to Locally Advanced Primary Urethral Carcinoma: A Case Report and Literature Review 6
The Impact of Routine Molecular Screening for SARS-CoV-2 in Patients Receiving Anticancer Therapy: An Interim Analysis of the Observational COICA Study 6
Management of gynaecomastia in patients with prostate cancer: a systematic review 6
Docetaxel Rechallenge in a Heavily Pretreated Patient with Castration-Resistant Prostate Cancer 6
Synergistic Combination of Quercetin and Mafosfamide in the Treatment of Bladder Cancer Cells 6
A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report 6
Expression of epidermal growth factor ( EGFR) correlates with disease relapse and progression to androgen –independence in human prostate cancer. 6
Weekly docetaxel and vinorelbine (VIN-DOX) as first line treatment in patients with hormone refractory prostate cancer 6
BAG3 protein delocalisation in prostate carcinoma 6
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer 6
Cisplatin- Versus Non-Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin 6
Prospective evaluation of entrainment mapping as an adjunct to new-generation high-density activation mapping systems of left atrial tachycardias 6
Neuroendocrine immunophenotype as predictor of clinical recurrence in 110 patients with prostate cancer 6
Expression of HECA-452 antigen correlates with disease relapse in mycosis fungoides 6
Totale 770
Categoria #
all - tutte 8.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.777 0 0 0 28 338 19 114 372 101 60 553 192
Totale 1.777